The Binaytara Northwest Women’s Cancer Conference is a CME-accredited activity featuring experts in breast cancer and gynecologic malignancies.

The BTF Northwest Women’s Cancer Conference is a CME-accredited activity featuring experts in breast cancer and gynecologic malignancies.

The 4th Binaytara Precision Oncology Summit is an annual 2-day CME-accredited national conference that offers an unparalleled opportunity for oncology professionals to delve into the latest advancements, innovations, and practices in precision oncology.

The 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes is an oncology conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations

The Alaska Multidisciplinary Oncology Conference is a 1-day educational and scientific meeting that will focus on key clinical topics in the management of common malignancies.

The 2023 International Cancer Congress (ICC2023) is the 5th annual oncology conference organized by the Binaytara Foundation in Janakpurdham, Nepal.

The 2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes is an oncology conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of implications of actionable molecular alterations across common malignancies. The conference will be October 7 - 8, 2022 in Salt Lake City, Utah!
This activity features recorded contents from our ASCO Direct Highlights oncology conference held on July 24-25, 2021 in Seattle. This activity is accredited for continuing education credits. You can only claim credits for this activity if you did not claim credits for the live, in-person meeting.
This is an educational meeting intended to improve the care of cancer patients by educating hematologists, oncologists, oncology pharmacists, oncology nurses and nurse practitioners and others involved in the management of cancer patients about the latest developments in the field. It is an officially licensed ASCO Direct™ Highlight: 2021 Official Annual Meeting Review.
Subscribe to RSS - Gynecologic Malignancies